Clinical Trial Update: Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer

View source ↗

Summary

A completed study evaluating ferumoxytol as an MRI contrast agent for lymph node imaging in patients with primary breast cancer or prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Prostate Cancer

Drugs mentioned

• FERUMOXYTOL (ferumoxytol)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Breast Cancer, Prostate Cancer | Status: COMPLETED